Hosted by The JC School of Public Health and Primary Care (JCSPHPC) of The Chinese University of Hong Kong (CUHK), the "SPHPC Thematic Research Seminar Series – Detecting cancer earlier in primary care: how might we do it and how much does it matter?" will take place on 17 April, 2025 (Thurs). In this seminar, Prof. Jon Emery, Professor of Primary Care Cancer Research at the University of Melbourne, will present trial examples of early cancer detection using risk-based screening and decision support tools, alongside their Data Connect program showing how diagnostic delays impact outcomes and the value of timely diagnosis.
Please refer to the details below:
Date: | 17 April 2025 (Thurs) |
Time: | 1:00 pm - 2:00 pm |
Venue: | KCTCRC, 1/F, School of Public Health Building, Prince of Wales Hospital, Shatin |
Mode: | Hybrid |
Topic: | Detecting cancer earlier in primary care: how might we do it and how much does it matter? |
Speaker: | Prof. Jon Emery Professor of Primary Care Cancer Research, University of Melbourne |
Moderator: | Prof. Martin Wong Professor, JC School of Public Health and Primary Care, Faculty of Medicine, the Chinese University of Hong Kong |
Presentation Abstract
Primary care plays a key role in the early detection of primary care, through implementation of cancer screening and investigation of patients presenting with symptoms of cancer. In this seminar, Prof. Jon Emery will present examples of our trials on approaches to detect cancer earlier, through risk-based screening and decision support tools. I will also present work from our Data Connect program demonstrating the associations of diagnostic delay on cancer outcomes and why timely diagnosis matters.
About the Speaker
Prof. Jon Emery is the Herman Professor of Primary Care Cancer Research at the University of Melbourne, and the Victorian Comprehensive Cancer Centre (VCCC) Primary Care Research and Education Lead. He is a National Health and Medical Research Council (NHMRC) Leadership Fellow, and Director of the Cancer Australia Primary Care Collaborative Cancer Clinical Trials Group (PC4).
Following his medical training at Cambridge and Oxford, he has had a successful career in academic primary care, initially at Oxford, where he obtained his DPhil on cancer risk assessment tools, then as a Cancer Research UK Clinician Scientist at Cambridge, before moving to Australia.
His research focuses on the application of advances in genetic medicine and the development and evaluation of complex interventions including computer decision support systems, and new cancer diagnostic and screening technologies. He is currently leading several trials related to risk-based cancer early detection in primary care.
In addition, he leads the VCCC Alliance Data Connect program, a data linkage initiative bringing together general practice data with multiple administrative datasets and clinical cancer registries to study the continuum of cancer care.
He will be moving to a new role in July 2025, focused on early cancer detection, at Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
About the Moderator
Prof. Martin C. S. Wong is a specialist in Family Medicine and a researcher in the field of cancer screening and prevention of chronic diseases. Prof. Wong has composed over three hundred publications in international peer-reviewed journals, and received over ten international and local research awards for studies in his research area. He is currently the Chairman of the Association of the Pacific Rim Universities, NCD stream; Co-Chairman of the Grant Review Board, Health and Medical Research Fund, Food and Health Bureau; the Convener of the Advisory Group on Hong Kong Reference Framework for Care of Diabetes and Hypertension in Primary Care Settings; a member of the Expert Advisory Panel in Implementation Science of the HKSAR government, and a member of the Research Council of the Food and Health Bureau. He is a reviewer of the Medical Research Council (MRC), United Kingdom; expert reviewer of the National Medical Research Council (NMRC), Singapore; external examiners of doctoral thesis in the University of Malaya; and an external reviewer of the Public Policy Research Funding Scheme, Research Grant Council (RGC) of Hong Kong. His enthusiasm to teaching has been well received by students and has been selected for the “Master Teacher” and the “Annual Teacher of the Year Award” for seven years.
He has devoted to serving the chronically ill patients and other vulnerable groups in Hong Kong and mainland China for over 20 years. Professor Wong was awarded the First Outstanding Volunteer Award by the Agency for Volunteer Service and the Hong Kong Humanity Award by Hong Kong Red Cross in 2005 and 2009, respectively. In 2010, he was conferred with an Award of benevolence by the Hong Kong, Macau and Taiwanese Charity Trust and the Radio Television Hong Kong, and the next year being named as the most outstanding NGO volunteer by the Correctional Services Department. Professor Wong was also selected as the Ten Outstanding Young Persons of Hong Kong in 2012. He is the only person in Hong Kong who received the Fervent Global Love of Lives Medal from the Chou TaKuan Cultural and Educational Foundation in 2012, an award recognized by the international media as “Nobel Prize of Lives”. In 2016, he was conferred as an Honorary Fellow by the Hong Kong Academy of Nursing to recognize his achievements in the profession and contributions to primary care. He was appointed as the Editor-in-Chief of the Hong Kong Academy of Medicine in 2017; a Fellow of the American College of Cardiology; a Fellow of the European Society of Cardiology; a Fellow and expert panel of the Academy of Translational Medicine, European Society of Translational Medicine; a Fellow of the Faculty of Public Health in 2018; and a Fellow of the Royal College of Physicians in 2019. He was appointed as an Adjunct Professor of the Peking Union Medical College in March 2019; and Adjunct Professor of Global Health by the Peking University.
Comments